LUMIGAN 0.01% EYE contains Bimatoprost which has a place with a gathering of medications known as prostamides. It is an enemy of glaucoma planning, used to diminish high pressing factor in the eye. It could be utilized all alone or with different drops called beta-blockers which additionally decrease pressure. Eyes contain an clear, watery fluid that takes care of within the eye. Fluid is habitually being depleted out of the eye and new fluid is made to supplant this. In the event that the fluid can’t empty out rapidly, the pressing factor inside the eye develops. Eliminate the contact lenses prior to applying this medication.
HOW LUMIGAN 0.01% EYE WORKS
LUMIGAN 0.01% EYE works by expanding the measure of fluid that is depleted which lessens the pressing factor inside the eye. On the off chance that the high pressing factor isn’t diminished, it could prompt a sickness called glaucoma and in the long run harm your sight. It lessens intraocular pressure (IOP) in people by causing an increment in surge of the fluid humor by means of the trabecular meshwork and uveoscleral pathways.
How to USE LUMIGAN OPHTHALMIC SOLUTION
This medication is for external utilization as it were. Take it in the portion and length as prompted by your PCP. Check the mark for headings before use. Hold the dropper near the eye without contacting it. Delicately crush the dropper and spot the medication inside the lower eyelid. Wipe off additional fluid.
What are the uses of LUMIGAN 0.01% EYE?
In Ocular hypertension
LUMIGAN 0.01% EYE has a place with a class of medications called prostaglandin simple. It is utilized to diminish pressure in your eyes. It expands the progression of liquid from inside the eye into the circulatory system consequently bringing down the expanded eye pressure. In the event that the pressing factor in your eye is excessively high, it can harm your sight. Take it routinely as recommended by your primary care physician. On the off chance that you quit taking it, the pressing factor in your eye won’t be controlled.
LUMIGAN 0.01% EYE Drop lessens pressure in your eyes (visual hypertension) that can prompt a sickness called glaucoma. It could be utilized alone or with other eye drops. Try not to utilize it time and again as that can make it less compelling. You should just utilize it in the influenced eye and take it consistently as recommended by your primary care physician. On the off chance that you quit taking it, the pressing factor in your eye won’t be controlled. This could prompt a deficiency of sight.
Symptoms OF LUMIGAN 0.01% EYE
Most results don’t need any clinical consideration and vanish as your body acclimates to the medication. Counsel your PCP in the event that they continue or in case you’re stressed over them
The most widely recognized symptoms of this medication incorporate conjunctival hyperemia and eye tingling. In the event that you get any results, converse with your primary care physician. They might have the option to disclose to you methods of decreasing or forestalling some results or propose another treatment. On the off chance that your vision is obscured or you have different changes in sight for a period, don’t drive until your vision is clear. This is generally a momentary result.
Side Effects of LUMIGAN 0.01% EYE
- Eye itching,
- Foreign body sensation in eyes
- Increased iris pigmentation
- Conjunctival hyperemia
- Burning sensation in eye
- Stinging in the eyes
- Eyelash changes
What if you forget to take LUMIGAN 0.01% EYE?
In the event that you miss a portion of LUMIGAN 0.01% EYE, skip it and proceed with your ordinary timetable. Try not to twofold the portion.
What occurs in the event that I quit utilizing LUMIGAN 0.01% EYE?
In the event that you quit utilizing LUMIGAN 0.01% EYE, the eyelashes may get back to their past appearance following a little while or months. On the off chance that you have built up any eyelid skin obscuring, it might invert following a little while or months. Be that as it may, any adjustment of the shade of the iris is perpetual and won’t switch.
There are no reviews yet.